Importantly, by generating Fibulin-4R/R|p21-Luciferase mice, we can now study the effect of therapeutic treatment on both senescence and aneurysm development simultaneously, as well as longitudinally, providing a tool to study potential new anti-senescence treatment options. Here, CDKN1A is linked to aneurysm.